APO Research
Talk to an analyst

APO RESEARCH · REPORT

GABA Stress Relief Gummies

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global GABA Stress Relief Gummies Market Outlook and Growth Opportunities 2026

29 December 2025193 pages

Choose your research edition.

Industry ResearchGABA Stress Relief Gummies Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal GABA Stress Relief Gummies Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal GABA Stress Relief Gummies Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GABA Stress Relief Gummies Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal GABA Stress Relief Gummies Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global GABA Stress Relief Gummies market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for GABA Stress Relief Gummies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for GABA Stress Relief Gummies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for GABA Stress Relief Gummies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the GABA Stress Relief Gummies market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the GABA Stress Relief Gummies market include Wonder Lab, Guangzhou Baiyunshan Pharmaceutical Group, VVN Naturals, Piping Rock Health Products, OLLY, NOW Foods, Nextdia, NEVISS and Nature's Truth, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global GABA Stress Relief Gummies market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of GABA Stress Relief Gummies and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents GABA Stress Relief Gummies sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the GABA Stress Relief Gummies market size, projected growth trends, production technologies, key applications, and end-use industries.

GABA Stress Relief Gummies Segment by Company

Wonder Lab

Guangzhou Baiyunshan Pharmaceutical Group

VVN Naturals

Piping Rock Health Products

OLLY

NOW Foods

Nextdia

NEVISS

Nature's Truth

Nature MadeGnite

LifeSeasons

HOLLEGEND

Emrald Labs

Duwhot

Carlyle

GABA Stress Relief Gummies Segment by Type

500mg

More than 500mg

Less than 500mg

GABA Stress Relief Gummies Segment by Application

Hospital

Pharmacy

Personal

Other

GABA Stress Relief Gummies Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global GABA Stress Relief Gummies status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions GABA Stress Relief Gummies market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify GABA Stress Relief Gummies significant trends, drivers, influence factors in global and regions.

6. To analyze GABA Stress Relief Gummies competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GABA Stress Relief Gummies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GABA Stress Relief Gummies and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GABA Stress Relief Gummies.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the GABA Stress Relief Gummies market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global GABA Stress Relief Gummies industry.

Chapter 3: Detailed analysis of GABA Stress Relief Gummies manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of GABA Stress Relief Gummies in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of GABA Stress Relief Gummies in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. GABA Stress Relief Gummies Industry Trends Table 2. GABA Stress Relief Gummies Industry Drivers Table 3. GABA Stress Relief Gummies Industry Opportunities and Challenges Table 4. GABA Stress Relief Gummies Industry Restraints Table 5. Global GABA Stress Relief Gummies Revenue by Company (US$ Million) & (2021-2026) Table 6. Global GABA Stress Relief Gummies Revenue Share by Company (2021-2026) Table 7. Global GABA Stress Relief Gummies Sales Volume by Company (Units) & (2021-2026) Table 8. Global GABA Stress Relief Gummies Sales Volume Share by Company (2021-2026) Table 9. Global GABA Stress Relief Gummies Average Price (US$/Unit) of Company (2021-2026) Table 10. Global GABA Stress Relief Gummies Company Ranking, (2024-2026) & (USD Million) Table 11. Global GABA Stress Relief Gummies Key Company Manufacturing Base & Headquarters Table 12. Global GABA Stress Relief Gummies Company, Product Type & Application Table 13. Global GABA Stress Relief Gummies Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global GABA Stress Relief Gummies by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 500mg Table 18. Significant Companies of More than 500mg Table 19. Significant Companies of Less than 500mg Table 20. Global GABA Stress Relief Gummies Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 21. Global GABA Stress Relief Gummies Sales Volume by Type (2021-2026) & (Units) Table 22. Global GABA Stress Relief Gummies Sales Volume by Type (2027-2032) & (Units) Table 23. Global GABA Stress Relief Gummies Sales Volume Share by Type (2021-2026) Table 24. Global GABA Stress Relief Gummies Sales Volume Share by Type (2027-2032) Table 25. Global GABA Stress Relief Gummies Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global GABA Stress Relief Gummies Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global GABA Stress Relief Gummies Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global GABA Stress Relief Gummies Sales Value Share by Type (2021-2026) Table 29. Global GABA Stress Relief Gummies Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Pharmacy Table 32. Significant Companies of Personal Table 33. Significant Companies of Other Table 34. Global GABA Stress Relief Gummies Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 35. Global GABA Stress Relief Gummies Sales Volume by Application (2021-2026) & (Units) Table 36. Global GABA Stress Relief Gummies Sales Volume by Application (2027-2032) & (Units) Table 37. Global GABA Stress Relief Gummies Sales Volume Share by Application (2021-2026) Table 38. Global GABA Stress Relief Gummies Sales Volume Share by Application (2027-2032) Table 39. Global GABA Stress Relief Gummies Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global GABA Stress Relief Gummies Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global GABA Stress Relief Gummies Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global GABA Stress Relief Gummies Sales Value Share by Application (2021-2026) Table 43. Global GABA Stress Relief Gummies Sales Value Share by Application (2027-2032) Table 44. Global GABA Stress Relief Gummies Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 45. Global GABA Stress Relief Gummies Sales by Region (2021-2026) & (Units) Table 46. Global GABA Stress Relief Gummies Sales Market Share by Region (2021-2026) Table 47. Global GABA Stress Relief Gummies Sales by Region (2027-2032) & (Units) Table 48. Global GABA Stress Relief Gummies Sales Market Share by Region (2027-2032) Table 49. Global GABA Stress Relief Gummies Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global GABA Stress Relief Gummies Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global GABA Stress Relief Gummies Sales Value Share by Region (2021-2026) Table 52. Global GABA Stress Relief Gummies Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global GABA Stress Relief Gummies Sales Value Share by Region (2027-2032) Table 54. Global GABA Stress Relief Gummies Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global GABA Stress Relief Gummies Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global GABA Stress Relief Gummies Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 57. Global GABA Stress Relief Gummies Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global GABA Stress Relief Gummies Sales by Country (2021-2026) & (Units) Table 59. Global GABA Stress Relief Gummies Sales Market Share by Country (2021-2026) Table 60. Global GABA Stress Relief Gummies Sales by Country (2027-2032) & (Units) Table 61. Global GABA Stress Relief Gummies Sales Market Share by Country (2027-2032) Table 62. Global GABA Stress Relief Gummies Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global GABA Stress Relief Gummies Sales Value Market Share by Country (2021-2026) Table 64. Global GABA Stress Relief Gummies Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global GABA Stress Relief Gummies Sales Value Market Share by Country (2027-2032) Table 66. Wonder Lab Company Information Table 67. Wonder Lab Business Overview Table 68. Wonder Lab GABA Stress Relief Gummies Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Wonder Lab GABA Stress Relief Gummies Product Portfolio Table 70. Wonder Lab Recent Development Table 71. Guangzhou Baiyunshan Pharmaceutical Group Company Information Table 72. Guangzhou Baiyunshan Pharmaceutical Group Business Overview Table 73. Guangzhou Baiyunshan Pharmaceutical Group GABA Stress Relief Gummies Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Guangzhou Baiyunshan Pharmaceutical Group GABA Stress Relief Gummies Product Portfolio Table 75. Guangzhou Baiyunshan Pharmaceutical Group Recent Development Table 76. VVN Naturals Company Information Table 77. VVN Naturals Business Overview Table 78. VVN Naturals GABA Stress Relief Gummies Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. VVN Naturals GABA Stress Relief Gummies Product Portfolio Table 80. VVN Naturals Recent Development Table 81. Piping Rock Health Products Company Information Table 82. Piping Rock Health Products Business Overview Table 83. Piping Rock Health Products GABA Stress Relief Gummies Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Piping Rock Health Products GABA Stress Relief Gummies Product Portfolio Table 85. Piping Rock Health Products Recent Development Table 86. OLLY Company Information Table 87. OLLY Business Overview Table 88. OLLY GABA Stress Relief Gummies Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. OLLY GABA Stress Relief Gummies Product Portfolio Table 90. OLLY Recent Development Table 91. NOW Foods Company Information Table 92. NOW Foods Business Overview Table 93. NOW Foods GABA Stress Relief Gummies Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. NOW Foods GABA Stress Relief Gummies Product Portfolio Table 95. NOW Foods Recent Development Table 96. Nextdia Company Information Table 97. Nextdia Business Overview Table 98. Nextdia GABA Stress Relief Gummies Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Nextdia GABA Stress Relief Gummies Product Portfolio Table 100. Nextdia Recent Development Table 101. NEVISS Company Information Table 102. NEVISS Business Overview Table 103. NEVISS GABA Stress Relief Gummies Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. NEVISS GABA Stress Relief Gummies Product Portfolio Table 105. NEVISS Recent Development Table 106. Nature's Truth Company Information Table 107. Nature's Truth Business Overview Table 108. Nature's Truth GABA Stress Relief Gummies Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Nature's Truth GABA Stress Relief Gummies Product Portfolio Table 110. Nature's Truth Recent Development Table 111. Nature MadeGnite Company Information Table 112. Nature MadeGnite Business Overview Table 113. Nature MadeGnite GABA Stress Relief Gummies Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Nature MadeGnite GABA Stress Relief Gummies Product Portfolio Table 115. Nature MadeGnite Recent Development Table 116. LifeSeasons Company Information Table 117. LifeSeasons Business Overview Table 118. LifeSeasons GABA Stress Relief Gummies Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. LifeSeasons GABA Stress Relief Gummies Product Portfolio Table 120. LifeSeasons Recent Development Table 121. HOLLEGEND Company Information Table 122. HOLLEGEND Business Overview Table 123. HOLLEGEND GABA Stress Relief Gummies Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. HOLLEGEND GABA Stress Relief Gummies Product Portfolio Table 125. HOLLEGEND Recent Development Table 126. Emrald Labs Company Information Table 127. Emrald Labs Business Overview Table 128. Emrald Labs GABA Stress Relief Gummies Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Emrald Labs GABA Stress Relief Gummies Product Portfolio Table 130. Emrald Labs Recent Development Table 131. Duwhot Company Information Table 132. Duwhot Business Overview Table 133. Duwhot GABA Stress Relief Gummies Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Duwhot GABA Stress Relief Gummies Product Portfolio Table 135. Duwhot Recent Development Table 136. Carlyle Company Information Table 137. Carlyle Business Overview Table 138. Carlyle GABA Stress Relief Gummies Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Carlyle GABA Stress Relief Gummies Product Portfolio Table 140. Carlyle Recent Development Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. GABA Stress Relief Gummies Distributors List Table 144. GABA Stress Relief Gummies Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. GABA Stress Relief Gummies Product Image Figure 2. Global GABA Stress Relief Gummies Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global GABA Stress Relief Gummies Sales Value (2021-2032) & (US$ Million) Figure 4. Global GABA Stress Relief Gummies Sales (2021-2032) & (Units) Figure 5. Global GABA Stress Relief Gummies Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global GABA Stress Relief Gummies Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 500mg Image Figure 10. More than 500mg Image Figure 11. Less than 500mg Image Figure 12. Global GABA Stress Relief Gummies Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 13. Global GABA Stress Relief Gummies Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global GABA Stress Relief Gummies Sales Volume Share by Type (2021-2032) Figure 15. Global GABA Stress Relief Gummies Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global GABA Stress Relief Gummies Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global GABA Stress Relief Gummies Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Pharmacy Image Figure 20. Personal Image Figure 21. Other Image Figure 22. Global GABA Stress Relief Gummies Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 23. Global GABA Stress Relief Gummies Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global GABA Stress Relief Gummies Sales Volume Share by Application (2021-2032) Figure 25. Global GABA Stress Relief Gummies Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global GABA Stress Relief Gummies Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global GABA Stress Relief Gummies Sales Value Share by Application (2021-2032) Figure 28. Global GABA Stress Relief Gummies Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 29. Global GABA Stress Relief Gummies Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global GABA Stress Relief Gummies Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global GABA Stress Relief Gummies Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America GABA Stress Relief Gummies Sales Value (2021-2032) & (US$ Million) Figure 33. North America GABA Stress Relief Gummies Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe GABA Stress Relief Gummies Sales Value (2021-2032) & (US$ Million) Figure 35. Europe GABA Stress Relief Gummies Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific GABA Stress Relief Gummies Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific GABA Stress Relief Gummies Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America GABA Stress Relief Gummies Sales Value (2021-2032) & (US$ Million) Figure 39. South America GABA Stress Relief Gummies Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa GABA Stress Relief Gummies Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa GABA Stress Relief Gummies Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. GABA Stress Relief Gummies Value Chain Figure 127. Manufacturing Cost Structure Figure 128. GABA Stress Relief Gummies Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • 500mg
  • More than 500mg
  • Less than 500mg
Applications
  • Hospital
  • Pharmacy
  • Personal
  • Other
Companies covered
  • Wonder Lab
  • Guangzhou Baiyunshan Pharmaceutical Group
  • VVN Naturals
  • Piping Rock Health Products
  • OLLY
  • NOW Foods
  • Nextdia
  • NEVISS
  • Nature's Truth
  • Nature MadeGnite
  • LifeSeasons
  • HOLLEGEND
  • Emrald Labs
  • Duwhot
  • Carlyle

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global GABA Stress Relief Gummies Sales Value (2021-2032)
  4. 1.2.2 Global GABA Stress Relief Gummies Sales Volume (2021-2032)
  5. 1.2.3 Global GABA Stress Relief Gummies Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 GABA Stress Relief Gummies Market Dynamics
  1. 2.1 GABA Stress Relief Gummies Industry Trends
  2. 2.2 GABA Stress Relief Gummies Industry Drivers
  3. 2.3 GABA Stress Relief Gummies Industry Opportunities and Challenges
  4. 2.4 GABA Stress Relief Gummies Industry Restraints
3 GABA Stress Relief Gummies Market by Company
  1. 3.1 Global GABA Stress Relief Gummies Company Revenue Ranking in 2025
  2. 3.2 Global GABA Stress Relief Gummies Revenue by Company (2021-2026)
  3. 3.3 Global GABA Stress Relief Gummies Sales Volume by Company (2021-2026)
  4. 3.4 Global GABA Stress Relief Gummies Average Price by Company (2021-2026)
  5. 3.5 Global GABA Stress Relief Gummies Company Ranking (2024-2026)
  6. 3.6 Global GABA Stress Relief Gummies Company Manufacturing Base and Headquarters
  7. 3.7 Global GABA Stress Relief Gummies Company Product Type and Application
  8. 3.8 Global GABA Stress Relief Gummies Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global GABA Stress Relief Gummies Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 GABA Stress Relief Gummies Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 GABA Stress Relief Gummies Market by Type
  1. 4.1 GABA Stress Relief Gummies Type Introduction
  2. 4.1.1 500mg
  3. 4.1.2 More than 500mg
  4. 4.1.3 Less than 500mg
  5. 4.2 Global GABA Stress Relief Gummies Sales Volume by Type
  6. 4.2.1 Global GABA Stress Relief Gummies Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global GABA Stress Relief Gummies Sales Volume by Type (2021-2032)
  8. 4.2.3 Global GABA Stress Relief Gummies Sales Volume Share by Type (2021-2032)
  9. 4.3 Global GABA Stress Relief Gummies Sales Value by Type
  10. 4.3.1 Global GABA Stress Relief Gummies Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global GABA Stress Relief Gummies Sales Value by Type (2021-2032)
  12. 4.3.3 Global GABA Stress Relief Gummies Sales Value Share by Type (2021-2032)
5 GABA Stress Relief Gummies Market by Application
  1. 5.1 GABA Stress Relief Gummies Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.1.3 Personal
  5. 5.1.4 Other
  6. 5.2 Global GABA Stress Relief Gummies Sales Volume by Application
  7. 5.2.1 Global GABA Stress Relief Gummies Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global GABA Stress Relief Gummies Sales Volume by Application (2021-2032)
  9. 5.2.3 Global GABA Stress Relief Gummies Sales Volume Share by Application (2021-2032)
  10. 5.3 Global GABA Stress Relief Gummies Sales Value by Application
  11. 5.3.1 Global GABA Stress Relief Gummies Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global GABA Stress Relief Gummies Sales Value by Application (2021-2032)
  13. 5.3.3 Global GABA Stress Relief Gummies Sales Value Share by Application (2021-2032)
6 GABA Stress Relief Gummies Regional Sales and Value Analysis
  1. 6.1 Global GABA Stress Relief Gummies Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global GABA Stress Relief Gummies Sales by Region (2021-2032)
  3. 6.2.1 Global GABA Stress Relief Gummies Sales by Region: 2021-2026
  4. 6.2.2 Global GABA Stress Relief Gummies Sales by Region (2027-2032)
  5. 6.3 Global GABA Stress Relief Gummies Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global GABA Stress Relief Gummies Sales Value by Region (2021-2032)
  7. 6.4.1 Global GABA Stress Relief Gummies Sales Value by Region: 2021-2026
  8. 6.4.2 Global GABA Stress Relief Gummies Sales Value by Region (2027-2032)
  9. 6.5 Global GABA Stress Relief Gummies Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America GABA Stress Relief Gummies Sales Value (2021-2032)
  12. 6.6.2 North America GABA Stress Relief Gummies Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe GABA Stress Relief Gummies Sales Value (2021-2032)
  15. 6.7.2 Europe GABA Stress Relief Gummies Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific GABA Stress Relief Gummies Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific GABA Stress Relief Gummies Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America GABA Stress Relief Gummies Sales Value (2021-2032)
  21. 6.9.2 South America GABA Stress Relief Gummies Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa GABA Stress Relief Gummies Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa GABA Stress Relief Gummies Sales Value Share by Country, 2025 VS 2032
7 GABA Stress Relief Gummies Country-level Sales and Value Analysis
  1. 7.1 Global GABA Stress Relief Gummies Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global GABA Stress Relief Gummies Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global GABA Stress Relief Gummies Sales by Country (2021-2032)
  4. 7.3.1 Global GABA Stress Relief Gummies Sales by Country (2021-2026)
  5. 7.3.2 Global GABA Stress Relief Gummies Sales by Country (2027-2032)
  6. 7.4 Global GABA Stress Relief Gummies Sales Value by Country (2021-2032)
  7. 7.4.1 Global GABA Stress Relief Gummies Sales Value by Country (2021-2026)
  8. 7.4.2 Global GABA Stress Relief Gummies Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt GABA Stress Relief Gummies Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt GABA Stress Relief Gummies Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt GABA Stress Relief Gummies Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Wonder Lab
  2. 8.1.1 Wonder Lab Company Information
  3. 8.1.2 Wonder Lab Business Overview
  4. 8.1.3 Wonder Lab GABA Stress Relief Gummies Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Wonder Lab GABA Stress Relief Gummies Product Portfolio
  6. 8.1.5 Wonder Lab Recent Developments
  7. 8.2 Guangzhou Baiyunshan Pharmaceutical Group
  8. 8.2.1 Guangzhou Baiyunshan Pharmaceutical Group Company Information
  9. 8.2.2 Guangzhou Baiyunshan Pharmaceutical Group Business Overview
  10. 8.2.3 Guangzhou Baiyunshan Pharmaceutical Group GABA Stress Relief Gummies Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Guangzhou Baiyunshan Pharmaceutical Group GABA Stress Relief Gummies Product Portfolio
  12. 8.2.5 Guangzhou Baiyunshan Pharmaceutical Group Recent Developments
  13. 8.3 VVN Naturals
  14. 8.3.1 VVN Naturals Company Information
  15. 8.3.2 VVN Naturals Business Overview
  16. 8.3.3 VVN Naturals GABA Stress Relief Gummies Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 VVN Naturals GABA Stress Relief Gummies Product Portfolio
  18. 8.3.5 VVN Naturals Recent Developments
  19. 8.4 Piping Rock Health Products
  20. 8.4.1 Piping Rock Health Products Company Information
  21. 8.4.2 Piping Rock Health Products Business Overview
  22. 8.4.3 Piping Rock Health Products GABA Stress Relief Gummies Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Piping Rock Health Products GABA Stress Relief Gummies Product Portfolio
  24. 8.4.5 Piping Rock Health Products Recent Developments
  25. 8.5 OLLY
  26. 8.5.1 OLLY Company Information
  27. 8.5.2 OLLY Business Overview
  28. 8.5.3 OLLY GABA Stress Relief Gummies Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 OLLY GABA Stress Relief Gummies Product Portfolio
  30. 8.5.5 OLLY Recent Developments
  31. 8.6 NOW Foods
  32. 8.6.1 NOW Foods Company Information
  33. 8.6.2 NOW Foods Business Overview
  34. 8.6.3 NOW Foods GABA Stress Relief Gummies Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 NOW Foods GABA Stress Relief Gummies Product Portfolio
  36. 8.6.5 NOW Foods Recent Developments
  37. 8.7 Nextdia
  38. 8.7.1 Nextdia Company Information
  39. 8.7.2 Nextdia Business Overview
  40. 8.7.3 Nextdia GABA Stress Relief Gummies Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Nextdia GABA Stress Relief Gummies Product Portfolio
  42. 8.7.5 Nextdia Recent Developments
  43. 8.8 NEVISS
  44. 8.8.1 NEVISS Company Information
  45. 8.8.2 NEVISS Business Overview
  46. 8.8.3 NEVISS GABA Stress Relief Gummies Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 NEVISS GABA Stress Relief Gummies Product Portfolio
  48. 8.8.5 NEVISS Recent Developments
  49. 8.9 Nature's Truth
  50. 8.9.1 Nature's Truth Company Information
  51. 8.9.2 Nature's Truth Business Overview
  52. 8.9.3 Nature's Truth GABA Stress Relief Gummies Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Nature's Truth GABA Stress Relief Gummies Product Portfolio
  54. 8.9.5 Nature's Truth Recent Developments
  55. 8.10 Nature MadeGnite
  56. 8.10.1 Nature MadeGnite Company Information
  57. 8.10.2 Nature MadeGnite Business Overview
  58. 8.10.3 Nature MadeGnite GABA Stress Relief Gummies Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Nature MadeGnite GABA Stress Relief Gummies Product Portfolio
  60. 8.10.5 Nature MadeGnite Recent Developments
  61. 8.11 LifeSeasons
  62. 8.11.1 LifeSeasons Company Information
  63. 8.11.2 LifeSeasons Business Overview
  64. 8.11.3 LifeSeasons GABA Stress Relief Gummies Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 LifeSeasons GABA Stress Relief Gummies Product Portfolio
  66. 8.11.5 LifeSeasons Recent Developments
  67. 8.12 HOLLEGEND
  68. 8.12.1 HOLLEGEND Company Information
  69. 8.12.2 HOLLEGEND Business Overview
  70. 8.12.3 HOLLEGEND GABA Stress Relief Gummies Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 HOLLEGEND GABA Stress Relief Gummies Product Portfolio
  72. 8.12.5 HOLLEGEND Recent Developments
  73. 8.13 Emrald Labs
  74. 8.13.1 Emrald Labs Company Information
  75. 8.13.2 Emrald Labs Business Overview
  76. 8.13.3 Emrald Labs GABA Stress Relief Gummies Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Emrald Labs GABA Stress Relief Gummies Product Portfolio
  78. 8.13.5 Emrald Labs Recent Developments
  79. 8.14 Duwhot
  80. 8.14.1 Duwhot Company Information
  81. 8.14.2 Duwhot Business Overview
  82. 8.14.3 Duwhot GABA Stress Relief Gummies Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Duwhot GABA Stress Relief Gummies Product Portfolio
  84. 8.14.5 Duwhot Recent Developments
  85. 8.15 Carlyle
  86. 8.15.1 Carlyle Company Information
  87. 8.15.2 Carlyle Business Overview
  88. 8.15.3 Carlyle GABA Stress Relief Gummies Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Carlyle GABA Stress Relief Gummies Product Portfolio
  90. 8.15.5 Carlyle Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 GABA Stress Relief Gummies Value Chain Analysis
  2. 9.1.1 GABA Stress Relief Gummies Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 GABA Stress Relief Gummies Sales Mode & Process
  6. 9.2 GABA Stress Relief Gummies Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 GABA Stress Relief Gummies Distributors
  9. 9.2.3 GABA Stress Relief Gummies Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst